You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biochemical recurrence

Showing 1 - 25 of 8,368
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)

Recruiting
  • Prostate Cancer
  • Biochemical Recurrence
  • Nanjing, Jiangsu, China
  • +1 more
Mar 2, 2023

Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)

Recruiting
  • Prostate Cancer Recurrent
  • CC-1 Infusion
  • Tuebingen, Germany
    University Hospital Tuebingen
Jan 10, 2023

Prostate Cancer Trial in Myrtle Beach (ChAdOx1-PCAQ, MVA-PCAQ)

Recruiting
  • Prostate Cancer
  • ChAdOx1-PCAQ
  • MVA-PCAQ
  • Myrtle Beach, South Carolina
    Carolina Urologic Research Center
Jan 30, 2023

Prostate Cancer Trial in Portland (Fluciclovine PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Fluciclovine PET/CT
  • Portland, Oregon
    Oreogn Health & Science University
Feb 1, 2023

Ovarian Cancer Trial in Guangzhou (Pamiparib/Tamoxifen)

Not yet recruiting
  • Ovarian Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Centre
Dec 30, 2022

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Biochemical Recurrence of Malignant Tumor of Prostate Trial (64Cu-SAR-BBN)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Duarte, California
  • +7 more
Jan 15, 2023

Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

Not yet recruiting
  • Prostate Cancer
  • +5 more
  • Radiopharmaceutical 18F-JK-PSMA-7
  • Radiopharmaceutical 18F-Fluorocholine
  • (no location specified)
Nov 17, 2022

Biochemical Recurrence of Malignant Tumor of Prostate Trial in United States (64Cu-SAR-bisPSMA)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Los Angeles, California
  • +5 more
Jun 21, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Mar 10, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Cancer of Prostate Trial in Bethesda, Philadelphia (Observation and Bicalutamide, Metformin and Bicalutamide)

Completed
Has Results
  • Cancer of Prostate
  • Observation and Bicalutamide
  • Metformin and Bicalutamide
  • Bethesda, Maryland
  • +1 more
Mar 2, 2022

Molecular Forms of PSA and Human Kallikrein 2 inCohort of

Active, not recruiting
  • Prostate Cancer
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Atlanta, Georgia
  • +3 more
Mar 9, 2023

Prostate Cancer Trial in Lexington (ArtemiCoffee)

Not yet recruiting
  • Prostate Cancer
  • Lexington, Kentucky
    University of Kentucky
Jul 25, 2022

Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Apalutamide 60mg Tab
  • Androgen deprivation therapy(ADT)
  • Nanjing, Jiangsu, China
  • +2 more
Mar 17, 2023

Biochemical Relapse Fo Malignant Tumor of Prostate Trial in Taipei (18F-FACBC PET/CT)

Recruiting
  • Biochemical Relapse Fo Malignant Neoplasm of Prostate
  • 18F-FACBC PET/CT
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 8, 2021

Prostate Cancer Trial in San Francisco (Ga-68 labeled PSMA-11 PET)

Completed
Has Results
  • Prostate Cancer
  • Ga-68 labeled PSMA-11 PET
  • San Francisco, California
    University of California, San Francisco
Sep 22, 2021

Prostate Cancer Trial in Seoul (Ga-68 PSMA-11 PET/CT imaging)

Active, not recruiting
  • Prostate Cancer
  • Ga-68 PSMA-11 PET/CT imaging
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Sep 27, 2021

PSMA PET/CT for Biochemical Recurrence Detection in Prostate

Completed
  • Prostatic Neoplasms
  • Recurrence
    • Brest, France
      Richard Pougnet
    Jul 29, 2021

    Prostate Cancer Trial in Duarte (genetic, other, procedure)

    Active, not recruiting
    • Prostate Cancer
    • DNA analysis
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Mar 17, 2022

    Prostatic Tumors, Prostate Cancer, Recurrence Trial in France, Spain, Switzerland ([18F]CTT1057, [68Ga]Ga-PSMA-11)

    Recruiting
    • Prostatic Neoplasms
    • +2 more
    • Marseille Cedex 05, France
    • +8 more
    Aug 9, 2022

    Prostate Cancer Patients With Biochemical Recurrence

    Active, not recruiting
    • Patients With Prostate Cancer
    • Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC)
    • Saint Louis, Missouri
      John Cochran VA Medical Center St. Louis
    May 10, 2022

    Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone Trial in Dallas (68Ga PSMA-11 injection,

    Recruiting
    • Prostate Cancer
    • +2 more
    • 68Ga PSMA-11 injection
    • Positron Emission Tomography/Computed Tomography
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 3, 2022